{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:06:05Z","timestamp":1789733165782,"version":"4.0.1"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872687"],"award-info":[{"award-number":["81872687"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.intimp.2020.107127","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T23:15:36Z","timestamp":1606000536000},"page":"107127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Emerging role of Fli1 in autoimmune diseases"],"prefix":"10.1016","volume":"90","author":[{"given":"Yi-Sheng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Feng","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2020.107127_b0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/imt-2019-0002","article-title":"Immunometabolism: an overview and therapeutic prospects in autoimmune diseases","volume":"11","author":"Stathopoulou","year":"2019","journal-title":"Immunotherapy"},{"issue":"3-4","key":"10.1016\/j.intimp.2020.107127_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","article-title":"Epidemiology of autoimmune diseases in Denmark","volume":"29","author":"Eaton","year":"2007","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"Mackay","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0025","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1073\/pnas.87.4.1332","article-title":"Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus.","volume":"87","author":"Ben-David","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00005-006-0017-z","article-title":"ETS transcription factors and regulation of immunity","volume":"54","author":"Gallant","year":"2006","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0035","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2020.107127_b0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2018.01088","article-title":"Aberrant T cell signaling and subsets in systemic lupus erythematosus","volume":"9","author":"Katsuyama","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.107127_b0045","doi-asserted-by":"crossref","unstructured":"M.K. Crow, Chapter 79 \u2013 Etiology and Pathogenesis of Systemic Lupus Erythematosus. In: G.S. Firestein, et al. (editors). Kelley and Firestein's Textbook of Rheumatology, tenth ed., Elsevier, 2017, pp. 1329\u20131344.","DOI":"10.1016\/B978-0-323-31696-5.00079-6"},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0050","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.immuni.2018.01.007","article-title":"Human T cell development, localization, and function throughout life","volume":"48","author":"Kumar","year":"2018","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0055","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1084\/jem.168.3.1061","article-title":"Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues.","volume":"168","author":"Haynes","year":"1988","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.autrev.2005.10.005","article-title":"Regulation of Fli1 gene expression and lupus","volume":"5","author":"Nowling","year":"2006","journal-title":"Autoimmun. Rev."},{"issue":"14","key":"10.1016\/j.intimp.2020.107127_b0065","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1242\/dev.126.14.3131","article-title":"Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage","volume":"126","author":"Anderson","year":"1999","journal-title":"Development"},{"issue":"15","key":"10.1016\/j.intimp.2020.107127_b0070","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","article-title":"Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1Transcription factor","volume":"20","author":"Spyropoulos","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.cmet.2017.06.016","article-title":"Metabolic regulation of T cell longevity and function in tumor immunotherapy","volume":"26","author":"Kishton","year":"2017","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0080","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1146\/annurev.immunol.021908.132706","article-title":"T cell activation","volume":"27","author":"Smith-Garvin","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jb\/mvi032","article-title":"The FLI-1 transcription factor is a short-lived phosphoprotein in T cells","volume":"137","author":"Zhang","year":"2005","journal-title":"J. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","article-title":"The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis","volume":"59","author":"Asano","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2020.107127_b0095","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/eji.201444442","article-title":"Fli-1 regulates the DN2 to DN3 thymocyte transition and promotes gammadelta T-cell commitment by enhancing TCR signal strength","volume":"44","author":"Smeets","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0100","first-page":"5551","article-title":"FLI1 levels impact CXCR3 expression and renal infiltration of T cells and renal glycosphingolipid metabolism in the MRL\/lpr lupus mouse strain","volume":"195","author":"Sundararaj","year":"2015","journal-title":"J.I."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/ar3528","article-title":"Mechanisms of tissue injury in lupus nephritis","volume":"13","author":"Nowling","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0110","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/jir.2011.0029","article-title":"The dysregulation of cytokine networks in systemic lupus erythematosus","volume":"31","author":"Apostolidis","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0115","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1002\/art.38818","article-title":"A critical role of the transcription factor fli-1 in murine lupus development by regulation of interleukin-6 expression","volume":"66","author":"Sato","year":"2014","journal-title":"Arthritis Rheumatol. (Hoboken, N.J.)"},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10753-015-0257-3","article-title":"Fli-1, a functional factor performed in autoimmune lupus","volume":"39","author":"Xu","year":"2016","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.090194","article-title":"Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Fas lpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus","volume":"37","author":"Cash","year":"2010","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0130","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.4049\/jimmunol.173.10.6481","article-title":"Decreased expression of the ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL\/lpr mice","volume":"173","author":"Zhang","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1521-3","article-title":"Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells","volume":"20","author":"Saigusa","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.intimp.2020.107127_b0140","doi-asserted-by":"crossref","first-page":"e75175","DOI":"10.1371\/journal.pone.0075175","article-title":"Reducing FLI1 levels in the MRL\/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism","volume":"8","author":"Richard","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0145","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107127_b0150","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: a reappraisal","volume":"51","author":"O'Reilly","year":"2012","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0155","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J. Neuroinflammat."},{"key":"10.1016\/j.intimp.2020.107127_b0160","doi-asserted-by":"crossref","first-page":"106378","DOI":"10.1016\/j.intimp.2020.106378","article-title":"The relationship between TIGIT+ regulatory T cells and autoimmune disease","volume":"83","author":"Lee","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1055\/s-2008-1042427","article-title":"Role of regulatory T cells for the treatment of type 1 diabetes mellitus","volume":"40","author":"Jaeckel","year":"2008","journal-title":"Horm. Metab. Res."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0170","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity","volume":"14","author":"Liston","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2020.107127_b0175","first-page":"3918","article-title":"Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes","volume":"186","author":"McClymont","year":"2011","journal-title":"J.I."},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0180","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin. Immunol."},{"issue":"14","key":"10.1016\/j.intimp.2020.107127_b0185","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","article-title":"CD161 defines the subset of FoxP3+ T cells capable of producing proinflammatory cytokines","volume":"121","author":"Pesenacker","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.clim.2012.09.006","article-title":"Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney","volume":"145","author":"Suzuki","year":"2012","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0195","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molimm.2014.07.013","article-title":"Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation","volume":"63","author":"Lennard Richard","year":"2015","journal-title":"Mol. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0200","first-page":"2661","article-title":"The Fli-1 transcription factor regulates the expression of CCL5\/RANTES","volume":"193","author":"Lennard Richard","year":"2014","journal-title":"J.I."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/cei.12310","article-title":"The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney","volume":"177","author":"Sato","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2020.107127_b0210","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.4049\/jimmunol.162.7.3840","article-title":"Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling","volume":"162","author":"Rabin","year":"1999","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2020.107127_b0215","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.177.9.5890","article-title":"T-bet controls pathogenicity of CTLs in the heart by separable effects on migration and effector activity","volume":"177","author":"Taqueti","year":"2006","journal-title":"J. Immunol."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2020.107127_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-2478(96)02666-1","article-title":"B-cell development in the mouse","volume":"54","author":"Rolink","year":"1996","journal-title":"Immunol. Lett."},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0225","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nri955","article-title":"Regulation of B-cell fate by antigen-receptor signals","volume":"2","author":"Niiro","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0230","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0235","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.4049\/jimmunol.181.3.1644","article-title":"The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice","volume":"181","author":"Zhang","year":"2008","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0240","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/MCB.15.12.6961","article-title":"An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes","volume":"15","author":"Zhang","year":"1995","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0245","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clim.2008.05.010","article-title":"A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis","volume":"129","author":"Bradshaw","year":"2008","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0250","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2249.2010.04245.x","article-title":"Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice","volume":"162","author":"Mathenia","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0255","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1084\/jem.188.12.2215","article-title":"The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells","volume":"188","author":"Dinkel","year":"1998","journal-title":"J. Exp. Med."},{"issue":"13","key":"10.1016\/j.intimp.2020.107127_b0260","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1182\/blood-2013-01-475772","article-title":"Deregulation of ETS1 and FLI1 contributes to the pathogenesis of diffuse large B-cell lymphoma","volume":"122","author":"Bonetti","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0265","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3892\/ijo.9.1.9","article-title":"Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome","volume":"9","author":"Georgiou","year":"1996","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0270","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/imm.12070","article-title":"The transcription factor Fli-1 regulates monocyte, macrophage and dendritic cell development in mice","volume":"139","author":"Suzuki","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2020.107127_b0275","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fimmu.2020.00800","article-title":"Fli1 downregulation in scleroderma myeloid cells has profibrotic and proinflammatory effects","volume":"11","author":"Bujor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2020.107127_b0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.molimm.2016.11.007","article-title":"The Fli-1 transcription factor is a critical regulator for controlling the expression of chemokine C-X-C motif ligand 2 (CXCL2)","volume":"81","author":"Lou","year":"2017","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcp.21750","article-title":"Role of connective tissue growth factor and its interaction with basic fibroblast growth factor and macrophage chemoattractant protein-1 in skin fibrosis","volume":"220","author":"Chujo","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0290","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0295","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1136\/annrheumdis-2013-204749","article-title":"High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci","volume":"74","author":"Kim","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1346-8138.2009.00758.x","article-title":"Future treatments in systemic sclerosis","volume":"37","author":"Asano","year":"2010","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0305","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/qjmed\/hcp174","article-title":"Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study","volume":"103","author":"Nihtyanova","year":"2010","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0310","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0315","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1128\/MCB.01278-08","article-title":"Transcription factor Fli1 regulates collagen fibrillogenesis in mouse skin","volume":"29","author":"Asano","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0320","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2020.107127_b0325","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.intimp.2020.107127_b0330","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/art.39312","article-title":"Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis","volume":"67","author":"Ichimura","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/exd.12602","article-title":"A possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis","volume":"24","author":"Saigusa","year":"2015","journal-title":"Exp. Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2020.107127_b0340","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/annrheumdis-2015-207483","article-title":"Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis","volume":"75","author":"Romano","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2020.107127_b0345","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0350","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2020.107127_b0355","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/art.24620","article-title":"Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen","volume":"60","author":"Ponticos","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2020.107127_b0360","first-page":"115","article-title":"Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in scleroderma","volume":"1","author":"Leask","year":"2009","journal-title":"Front Biosci. (Elite Ed.)"},{"issue":"21","key":"10.1016\/j.intimp.2020.107127_b0365","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0370","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-4-4","article-title":"Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease","volume":"4","author":"Wang","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"Suppl 100(5)","key":"10.1016\/j.intimp.2020.107127_b0375","first-page":"14","article-title":"Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis","volume":"34","author":"Lei","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107127_b0380","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1002\/art.34643","article-title":"Potential roles of interleukin-17A in the development of skin fibrosis in mice","volume":"64","author":"Okamoto","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"7090","key":"10.1016\/j.intimp.2020.107127_b0385","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2020.107127_b0390","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0395","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/art.40016","article-title":"Scleroderma peripheral B lymphocytes secrete interleukin-6 and transforming growth factor beta and activate fibroblasts","volume":"69","author":"Dumoitier","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0400","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","article-title":"IL-6 switches the differentiation of monocytes from dendritic cells to macrophages","volume":"1","author":"Chomarat","year":"2000","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0405","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood-2004-02-0701","article-title":"Monocyte-like and mature macrophages produce CXCL13 (B cell-attracting chemokine 1) in inflammatory lesions with lymphoid neogenesis","volume":"104","author":"Carlsen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2020.107127_b0410","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.biocel.2015.06.004","article-title":"Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis","volume":"67","author":"Asano","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0415","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.intimp.2020.107127_b0420","doi-asserted-by":"crossref","first-page":"e32272","DOI":"10.1371\/journal.pone.0032272","article-title":"A possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis","volume":"7","author":"Noda","year":"2012","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0425","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch. Dermatol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0430","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/art.39062","article-title":"Endothelin receptor blockade ameliorates vascular fragility in endothelial cell-specific Fli-1\u2013knockout mice by increasing Fli-1 DNA binding ability","volume":"67","author":"Akamata","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0435","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1248\/bpb.27.772","article-title":"Role of aminopeptidase in angiogenesis","volume":"27","author":"Sato","year":"2004","journal-title":"Biol. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0440","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.yexcr.2005.10.019","article-title":"Pericytes and vascular stability","volume":"312","author":"von Tell","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0445","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0450","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI42918","article-title":"Specialized roles for cysteine cathepsins in health and disease","volume":"120","author":"Reiser","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2020.107127_b0455","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/03008200802143158","article-title":"Role of cysteine cathepsins in matrix degradation and cell signalling","volume":"49","author":"Obermajer","year":"2008","journal-title":"Connect Tissue Res."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0460","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.2353\/ajpath.2010.091027","article-title":"Cathepsin L in bone marrow-derived cells is required for retinal and choroidal neovascularization","volume":"176","author":"Shimada","year":"2010","journal-title":"Am. J. Pathol."},{"issue":"43","key":"10.1016\/j.intimp.2020.107127_b0465","doi-asserted-by":"crossref","first-page":"37158","DOI":"10.1074\/jbc.M111.284869","article-title":"Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin","volume":"286","author":"Veillard","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0470","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/exd.12920","article-title":"A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis","volume":"25","author":"Yamashita","year":"2016","journal-title":"Exp. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0475","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrd4226","article-title":"Aquaporins: important but elusive drug targets","volume":"13","author":"Verkman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0480","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jdermsci.2018.09.007","article-title":"Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis","volume":"93","author":"Yamashita","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0485","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/exd.13341","article-title":"The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis","volume":"26","author":"Toyama","year":"2017","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0490","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.14699","article-title":"A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis","volume":"175","author":"Takahashi","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"22","key":"10.1016\/j.intimp.2020.107127_b0495","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2020.107127_b0500","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cden.2013.06.003","article-title":"Systemic lupus erythematosus: epidemiology, pathophysiology, manifestations, and management","volume":"57","author":"Fortuna","year":"2013","journal-title":"Dent. Clin. North Am."},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0505","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/eji.201646315","article-title":"Acetylation impacts Fli-1-driven regulation of granulocyte colony stimulating factor","volume":"46","author":"Lennard Richard","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.107127_b0510","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/jir.2011.0029","article-title":"The dysregulation of cytokine networks in systemic lupus erythematosus","volume":"31","author":"Apostolidis","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.intimp.2020.107127_b0515","doi-asserted-by":"crossref","first-page":"105680","DOI":"10.1016\/j.intimp.2019.105680","article-title":"Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production","volume":"74","author":"Li","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.107127_b0520","first-page":"432595","article-title":"Inflammatory cytokines in systemic lupus erythematosus","volume":"2011","author":"Ohl","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0525","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10067-019-04467-8","article-title":"Upregulated expression of STAT3\/IL-17 in patients with systemic lupus erythematosus","volume":"38","author":"Chen","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.intimp.2020.107127_b0530","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12865-015-0070-7","article-title":"IL-17 and IL-23 in lupus nephritis \u2013 association to histopathology and response to treatment","volume":"16","author":"Zickert","year":"2015","journal-title":"BMC Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2020.107127_b0535","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5152\/eurjrheum.2017.16059","article-title":"IL-17A levels in systemic lupus erythematosus associated with inflammatory markers and lower rates of malignancy and heart damage: evidence for a dual role","volume":"4","author":"Raymond","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"10.1016\/j.intimp.2020.107127_b0540","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.clim.2016.04.010","article-title":"T cells and IL-17 in lupus nephritis","volume":"185","author":"Koga","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.107127_b0545","doi-asserted-by":"crossref","first-page":"715190","DOI":"10.1155\/2012\/715190","article-title":"Immunopathological roles of cytokines, chemokines, signaling molecules, and pattern-recognition receptors in systemic lupus erythematosus","volume":"2012","author":"Yu","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2020.107127_b0550","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0555","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00191429","article-title":"Cellular localization of inflammatory cytokines in human glomerulonephritis","volume":"424","author":"Takemura","year":"1994","journal-title":"Virchows Arch."},{"issue":"6","key":"10.1016\/j.intimp.2020.107127_b0560","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/art.30284","article-title":"The c-Abl tyrosine kinase controls protein kinase C\u03b4-induced Fli-1 phosphorylation in human dermal fibroblasts","volume":"63","author":"Bujor","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.intimp.2020.107127_b0565","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1128\/MCB.01320-08","article-title":"Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300\/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor beta","volume":"29","author":"Asano","year":"2009","journal-title":"Mol. Cell. Biol."},{"issue":"48","key":"10.1016\/j.intimp.2020.107127_b0570","doi-asserted-by":"crossref","first-page":"34672","DOI":"10.1074\/jbc.M703907200","article-title":"Transforming growth factor-beta regulates DNA binding activity of transcription factor Fli1 by p300\/CREB-binding protein-associated factor-dependent acetylation","volume":"282","author":"Asano","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.intimp.2020.107127_b0575","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1365-2133.2012.11055.x","article-title":"Constitutive activation of c-Abl\/protein kinase C-\u03b4\/Fli1 pathway in dermal fibroblasts derived from patients with localized scleroderma","volume":"167","author":"Noda","year":"2012","journal-title":"Br. J. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920335943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920335943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T04:28:21Z","timestamp":1744950501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920335943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":115,"alternative-id":["S1567576920335943"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107127","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of Fli1 in autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.107127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107127"}}